Antimicrobial peptides from platelets

Drug Resistance Updates

Volumn 2, Issue 2, 1999, Pages 116-126

  Yeaman, Michael R ^a   Bayer, Arnold S ^a  

^a St John's Cardiovascular Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PEPTIDE;

ANTIMICROBIAL ACTIVITY; BACTERIAL COLONIZATION; BACTERIAL MEMBRANE; BLOOD VESSEL INJURY; HOST RESISTANCE; LEUKOCYTE FUNCTION; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

EID: 0033022973     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1054/drup.1999.0069     Document Type: Article

References (93)

1. Yeaman M. R. The role of platelets in antimicrobial host defense. Clin Infect Dis. 25:1997;951-970.
2. Scheld W. M., Valone J. A., Sande M. A. Bacterial adherence in the pathogenesis of infective endocarditis: interaction of dextran, platelets, & fibrin. J Clin Invest. 61:1978;1394-1404.
3. Durack D. T. Experimental bacterial endocarditis. IV. Structure and evolution of very early lesions. J Clin Pathol. 45:1975;81-89.
4. Calderone R. A., Rotondo M. F., Sande M. A. Candida albicans endocarditis: ultrastructural studies of vegetation formation. Infect Immun. 20:1978;279-289.
5. Durack D. T., Beeson P. B., Petersdorf R. G. Experimental bacterial endocarditis. III. Production of progress of the disease in rabbits. Br J Exp Pathol. 54:1973;142-151.
6. Sullam P. M., Drake T. A., Sande M. A. Pathogenesis of endocarditis. Amer J Med. 78:1985;110-115.
7. Ferguson D. J. P., McColm A. A., Savage T. J., Ryan D. M., Acred P. A morphological study of experimental rabbit staphylococcal endocarditis and aortitis. I. Formation and effect of infected and uninfected vegetations on the aorta. Br J Exp Pathol. 67:1986;667-678.
8. Scheld W. M., Sande M. A. Endocarditis and intravascular infections. Mandell G. L., Bennet J. E., Dolin R. Principles and Practice of Infectious Diseases 5th ed. 1995;740-782 Churchill Livingstone, New York.
9. Clawson C. C. Role of platelets in the pathogenesis of endocarditis. In Infectious Endocarditis. Amer Heart Assoc Monograph. 52:1977;24-27.
10. Roberts W. C., Buchbinder N. A. Right-sided valvular infective endocarditis: a clinicopathologic study of 12 necropsy patients. Amer J Med. 53:1972;7-19.
11. Buchbinder N. A., Roberts W. C. Left-sided valvular infective endocarditis: a study of 45 necropsy patients. Amer J Med. 53:1972;20-35.
12. Vinter D. W., Burkel W. E., Wakefield T. W. Radioisotope-labeled platelet studies and infection of vascular grafts. J Vasc Surg. 6:1984;921-923.
13. Fodor J. Die fahigkeit des blutes bakterien zu vernichten. Dtsch. Med. Wochenschr. 13:1887;745-747.
14. Gengou O. DE 1=origine de 1=axenine de serums normaux. Ann Inst Pasteur (Paris). 15:1901;232-245.
15. Hirsch J. G. Comparative bactericidal activities of blood serum and plasma serum. J Exp Med. 112:1960;15-22.
16. Carroll S. F., Martinez R. J. Antibacterial peptide from normal rabbit serum. I. Isolation from whole serum, activity, and microbiologic spectrum. Biochem. 20:1981;5973-5981.
17. Carroll S. F., Martinez R. J. Antibacterial peptide from normal rabbit serum. II. Compositional microanalysis. Biochem. 20:1981;5981-5987.
18. Carroll S. F., Martinez R. J. Antibacterial peptide from normal rabbit serum. III. Inhibition of microbial electron transport. Biochem. 20:1981;5988-5994.
19. Myrvik Q. N. Serum bactericidins active against gram-positive bacteria. Ann NY Acad Sci. 66:1956;391-400.
20. Cellular source and character of a heat-stable bactericidal property associated with rabbit and rat platelets. J Exp Med, 113, 701, 709.
21. Myrvik Q. N., Leake E. S. Studies on antibacterial factors in mammalian tissues and fluids. IV. Demonstration of two non-dialyzable components in the serum bactericidin system for Bacillus subtilis. J Immunol. 84:1960;247-250.
22. Johnson F. B., Donaldson D. M. Purification of staphylocidal β-lysin from rabbit serum. J Bacteriol. 96:1968;589-595.
23. Donaldson D. M., Tew J. G. β-Lysin of platelet origin. Bacteriol Rev. 41:1977;501-512.
24. Weksler B. B., Nachman R. L. Rabbit platelet bactericidal protein. J Exp Med. 134:1971;1114-1130.
25. Tew J. G., Roberts R. R., Donaldson D. M. Release of β-lysin from platelets by thrombin and by a factor produced in heparinized blood. Infect Immun. 9:1974;179-186.
26. Jago R., Jacox R. F. Cellular source and character of a heat-stable bactericidal property associated with rabbit and rat platelets. J Exp Med. 113:1961;701-709.
27. Darveau R. P., Blake J., Seachord C. L., Cosand W. L., Cunningham M. D., Cassiano-Cough L., Maloney G. Peptide related to the carboxy-terminus of human platelet factor IV with antibacterial activity. J Clin Invest. 90:1992;447-455.
28. Dankert, J. Role of platelets in early pathogenesis of viridans group streptococcal endocarditis. Ph.D, University of Groningen, Groningen, 1988.
29. Dankert J., van der Werff J., Zaat S. A. J., Joldersma W., Klein D., Hess J. Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis. Infect Immun. 63:1995;663-671.
30. Yeaman M. R., Puentes S. M., Norman D. C., Bayer A. S. Partial purification and staphylocidal activity of thrombin-induced platelet microbicidal protein. Infect Immun. 60:1992;1202-1209.
31. Yeaman M. R., Tang Y-Q., Shen A. J., Bayer A. S., Selsted M. E. Purification and in vitro activities of rabbit platelet microbicidal proteins. Infect Immun. 65:1997;1023-1031.
32. Bancsi M. J. L. F., Thompson J., Bertina R. M. Stimulation of monocyte tissue factor expression in an in vitro model of bacterial endocarditis. Infect Immun. 62:1994;5669-5672.
33. Drake T. A., Pang M. Staphylococcus aureus induces tissue factor expression in cultured human cardiac valve endothelium. J Infect Dis. 157:1988;749-756.
34. Drake T. A., Rodgers G. M., Sande M. A. Tissue factor is a major stimulus for vegetation formation in enterococcal endocarditis in rabbits. J Clin Invest. 73:1984;1750-1753.
35. Azizi N., Li C., Shen A. J., Bayer A. S., Yeaman M. R. Staphylococcus aureus elicits release of platelet microbicidal proteins in vitro. Abstract no. 866. 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans. 1996.
36. Ramos M., Yeaman M. R., Cheung A. L. Hyperproduction of α-toxin by Staphylococcus aureus results in paradoxically-reduced virulence in experimental endocarditis: a possible host defense role for platelet microbicidal proteins (PMPs). Abstract no. 258. 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996.
37. Yeaman M. R., Ibrahim A., Filler S. G., Bayer A. S., Edwards J. E., Ghannoum M. A. Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro. Antimicrob Agents Chemother. 37:1993;546-553.
38. Ganz T., Selsted M. E., Lehrer R. I. Defensins. Eur J Haematol. 44:1990;1-8.
39. Tang Y. Q., Yeaman M. R., Selsted M. E. Purfication, characterization, and antimicrobial properties of peptides released from thrombin-induced human platelets. Blood 86 (No. 10): 910a. Abstract no. 3626, American Society of Hematology 37th annual meeting. Seattle, WA, 1995.
40. Tang Y. Q., Yeaman M. R., Selsted M. E. Microbicidal and synergistic activities of human platelet factor-4 (hPF-4) and connective tissue activating peptide-3 (CTAP-3). Blood. 86:1995.
41. Krijgsveld J., Zaat S. A., Kuijpers A. J., Engbers G. H., Feijen J., Dankert J. Thrombocidins, bactericidal proteins from human blood platelets, are C-terminal deletion products of CXC-chemokines. Abstract no. F-179. 38th ICAAC, American Society for Microbiology, San Diego, CA. 1998.
42. Yeaman M. R., Bayer A. S., Koo S. P., Foss W., Sullam P. M. Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action. J Clin Invest. 101:1998;178-187.
43. Koo S. P., Bayer A. S., Sahl H. G., Proctor R. A., Yeaman M. R. Staphylocidal action of thrombin-induced platelet microbicidal protein is not solely dependent on transmembrane potential. Infect Immun. 64:1996;1070-1074.
44. Zasloff M. Antibiotic peptides as mediators of innate immunity. Curr Opin Immunol. 4:1992;3-8.
45. Bowman H. G. Antibacterial peptides: key components in immunity. Cell. 65:1995;205-211.
46. Taylor R. Drugs R Us: finding new antibiotics at the endogenous pharmacy. J NIH Res. 5:1993;59-63.
47. Koo S. P., Yeaman M. R., Bayer A. S. Staphylocidal action of thrombin-induced platelet microbicidal protein is influenced by microenvironment and target cell growth phase. Infect. Immun. 64:1996;3758-3764.
48. Koo S. P., Yeaman M. R., Nast C. C., Bayer A. S. The cytoplasmic membrane is a primary target for the staphylocidal action of thrombin-induced platelet microbicidal protein. Infect Immun. 65:1997;4795-4800.
49. Koo S. P., Bayer A. S., Kagan B. L., Yeaman M. R. Membrane permeabilization by thrombin-induced platelet microbicidal protein-1 is modulated by transmembrane voltage polarity and magnitude. Infect Immun. 67:1999.
50. Xiong, Y. Q. Yeaman, M. R. Bayer, A. S. In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action. Antimicrob Agents Chemother, 43.
51. Van Den Broek P. J., Bril-Bazuin C., Mattie H. Antibacterial activity of defensins against Staphylococcus aureus pretreated with benzyl penicillin or azithromycin. Abstract no. C-88. 36th ICAAC, American Society for Microbiology, New Orleans, LA, 1996.
52. Asensi V., Fierer J. Synergistic effect of human lysozyme plus ampicillin or β-lysin on the killing of Listeria monocytogenes. J Infect Dis. 163:1991;574-578.
53. Yeaman M. R., Norman D. C., Bayer A. S. Platelet microbicidal protein enhances antibiotic-induced killing of and post-antibiotic effect in Staphylococcus aureus. Antimicrob Agents Chemother. 36:1992;1665-1670.
54. Yeaman M. R., Sullam P. M., Dazin P. F., Bayer A. S. Characterization of Staphylococcus aureus -platelet binding by quantitative flow cytometric analysis. J Infect Dis. 166:1992;65-73.
55. Yeaman M. R., Sullam P. M., Dazin P. F., Bayer A. S. Platelet microbicidal protein alone and in combination with antibiotics reduces Staphylococcus aureus adherence to platelets in vitro. Infect Immun. 62:1994;3416-3423.
56. Bayer A. S., Sullam P. M., Ramos M., Li C., Cheung A. L., Yeaman M. R. Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains. Infect Immun. 63:1995;3634-3641.
57. Sullam P. M., Jarvis G. A., Valone F. H. Role of immunoglobulin G in platelet aggregation by viridans group streptococci. Infect Immun. 56:1988;2907-2911.
58. Bayer A. S., Ramos M., Yeaman M. R., Menzies B. E., Shen A. J., Cheung A. L. Hyperproduction of α-toxin by Staphylococcus aureus results in paradoxically-reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins. Infect Immun. 65:1997;4652-4660.
59. Nachman R. L., Weksler B. B. The platelet as an imflammatory cell. Ann NY Acad Sci. 201:1972;131-137.
60. Lellouch-Tubiana A., Lefort J., Simon M-T., Pfister A., Vargaftig B. B. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists. Am Rev Respir Dis. 137:1988;948-954.
61. Jungi T. W., Spycher M. O., Nydegger V. E., Barandun S. Platelet-leukocyte interactions: selective binding of thrombin-stimulated platelets to human monocytes, polymorphonuclear leukocytes and related cell lines. Blood. 67:1986;629-636.
62. Silverstein R., Nachman R. L. Thrombospondin mediates the interaction of stimulated platelets with monocytes. J Clin Invest. 79:1987;867-874.
63. Burns G. F., Cosgrove L., Triglia T. The IIb-IIIa glycoprotein complex that mediates platelet aggregation is directly implicated in leukocyte adhesion. Cell. 45:1986;269-280.
64. Weksler B. B. Platelets. Gallin J. I., Goldstein I. M., Snyderman R. Inflammation: Basic Principles and Clinical Correlates, 2nd edition. 1992;Raven Press Ltd, New York.
65. Colman R. W. Receptors that activate platelets. Proc Soc Exp Biol Med. 197:1991;242-248.
66. Mehta P., Mehta J., Lawson D. Leukotrienes potentiate the effects of epinephrine and thrombin on human platelet-aggregation. Thromb Res. 41:1986;731-738.
67. Schwartz B. F., Monroe M. C. Human platelet aggregation is initiated by peripheral blood mononuclear cells exposed to bacterial lipopolysaccharide in vitro. J Clin Invest. 78:1986;1136-1141.
68. Mandell G. L., Hook E. W. The interaction of platelets, Salmonella, and mouse peritoneal macrophages. Proc Soc Exp Biol Med. 132:1969;757-759.
69. Schroder J. M., Sticherling M., Persoon N. L., Christopers E. Identification of a novel platelet-derived neutrophil-chemotactic polypeptide with structural homology to platelet factor-4. Biochem Biophys Res Comm. 172:1990;898-904.
70. Deuel T. F., Senior R. M., Chang D., Griffith G. L., Heinrikson R. L., Kaiser E. T. Platelet factor-4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci [USA]. 78:1981;4548-4587.
71. Boogaerts M. A., Yamada O., Jacob H. S., Moldow C. F. Enhancement of granulocyte-endothelial cell adherence and granulocyte-induced cytotoxicity by platelet release products. Proc Natl Acad Sci (USA). 79:1982;7019-7023.
72. 2mediates augmented polymorphonuclear leukocyte adhesiveness. 1980.
73. Pancré V., Monte D., Delanoye A., Capron A., Aurialt C. Interleukin-6, the main mediator of interaction between monocytes and platelets in killing of Schistosoma mansoni. Eur Cytokine Net. 1:1990;15-19.
74. Christin L., Wysong D. R., Meshulam T., Hastey R., Simons E. R., Diamond R. D. Human platelets damage Aspergillus fumigatus hyphae and may supplement killing by neutrophils. Infect Immun. 66:1998;1181-1189.
75. Wu T., Yeaman M. R., Bayer A. S. In vitro resistance to platelet microbicidal protein correlates with endocarditis source among staphylococcal isolates. Antimicrob Agents Chemother. 38:1994;729-732.
76. Bayer A. S., Cheng D., Yeaman M. R. In vitro resistance to thrombin-induced platelet microbicidal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source. Antimicrob Agents Chemo. 42:1998;3169-3172.
77. Groisman E. A., Parra-Lopez C., Salcedo M., Lipps C. J., Heffron F. Resistance to host antimicrobial peptides in necessary for Salmonella virulence. Proc Natl Acad Sci. 89:1997;11939-11943.
78. Fields P. L., Groisman E. A., Heffron F. A Salmonella locus that controls resistance to microbicidal proteins from phagocytic cells. Science. 243:1989;1059-1062.
79. Guo L., Lim K. B., Poduje C. M., Daniel M., Gunn J. S., Hackett M., Miller S. I. Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell. 95:1998;189-198.
80. Viscoli C., Bruzzi P., Castagnola E. Factors associated with bacteraemia in febrile, granulocytopenic patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer. 30:1994;430-437.
81. Feldman C., Kallenbach J. M., Levy H., Thorburn J. R., Hurwitz M. D., Koornhof H. J. Comparision of bacteraemic community-acquired lobar pneumonia due to Streptococcus pneumoniae andKlebsiella pneumoniae in an intensive care unit. Respiration. 58:1991;265-270.
82. Korzweniowski O. M., Scheld W. M., Bithell T. C., Croft B. H., Sande M. A. The effect of aspirin on the production of experimental Staphylococcus aureus endocarditis [abstract]. Program Abstracts of the 19th Interscience Conference on Antimicrobial Agents and Chemotherapy (Boston). 1979;American Society for Microbiology, Washington, D.C.
83. Sullam P. M., Frank U., Yeaman M. R., Tauber M. G., Bayer A. S., Chambers H. F. Effect of thrombocytopenia on the early course of streptococcal endocarditis. J Infect Dis. 168:1993;910-914.
84. Berney P., Francioli P. Successful prophylaxis of experimental streptococcal endocarditis with single-dose amoxicillin administered after bacterial challenge. J Infect Dis. 161:1990;281-285.
85. Yersin B. R., Glauser M. P., Freedman L. R. Effect of nitrogen mustard on natural history of right-sided streptococcal endocarditis in rabbits: role for cellular host defenses. Infect Immun. 35:1982;320-325.
86. Yeaman M. R., Soldan S. S., Ghannoum M., Edwards J. E., Filler S. G., Bayer A. S. Resistance to platelet microbicidal protein results in the increased severity of experimental Candida albicans endocarditis. Infect Immun. 64:1996;1379-1384.
87. Dhawan V. K., Yeaman M. R., Kim E., Bayer A. S. Phenotypic resistance to thrombin-induced platelet microbicidal protein in vitro is correlated with enhanced virulence in experimental endocarditis due to Staphylococcus aureus. Infect Immun. 65:1997;3293-3299.
88. Dhawan V. K., Bayer A. S., Yeaman M. R. In vitro resistance to thrombin-induced platelet microbicidal protein is associated with enhanced progression and hematogenous dissemination in experimental Staphylococcus aureus infective endocarditis. Infect Immun. 66:1998;3476-3479.
89. Bayer A. S., Yeaman M. R., Sahl H. G., Brar D., Proctor R. A. Relationship of phenotypic resistance to thrombin-induced platelet microbicidal protein (tPMP) and cytoplasmic membrane bioenergetics in Staphylococcus aureus. Abstract no. A-106. 97th General Meeting of the American Society for Microbiology, Miami, FL. 1997.
90. Bayer A. S., Yeaman M. R., Koo S. P., Prasad R. Resistance to staphylocidal effects of thrombin-induced platelet microbicidal protein (tPMP) is associated with alterations in membrane fluidity and lipid composition. Abstract no. A-107. 97th General Meeting of the American Society for Microbiology, Miami, FL. 1997.
91. Kupferwasser L. I., Bayer A. S., Brown M. H., Firth N., Yeaman M. R., Skurray R. A. Staphylococcus aureus resistance to thrombin-induced platelet microbicidal protein (tPMP-1) is encoded by the multi-resistance plasmid pSK1. Abstract no. C-102. 38th ICAAC, American Society for Microbiology, San Diego, CA. 1998.
92. Yeaman M. R., Joshi M. D., Gank K. D., Kahler D., Welch W. H. Structural correlates in mechanisms of cationic antimicrobial peptide action. Abstract no. F-170. 38th ICAAC, San Diego, CA, American Society for Microbiology. 1998.
93. Packham M. A., Rand M. L., Kinlough-Rathbone R. L. Similarities and differences between rabbit and human platelet characteristics and functions. Comp Biochem Physiol. 103A:1992;35-54.